Welcome to LookChem.com Sign In|Join Free
  • or
3-(N-2-fluorobenzoylcarbamimidoyl)-benzoic acid methyl ester is a complex organic compound with the molecular formula C16H12FNO4. It is a derivative of benzoic acid, featuring a methyl ester group, a carbamimidoyl moiety, and a 2-fluorobenzoyl group. This chemical is characterized by its potential applications in pharmaceutical research, particularly as a building block for the synthesis of various biologically active molecules. The presence of the fluorine atom in the 2-position of the benzoyl group can influence the compound's reactivity and binding properties, making it a valuable intermediate in the development of new drugs. The compound's structure and properties make it a subject of interest for chemists and biologists alike, as it can be used to probe the effects of fluorination on molecular interactions and to create new therapeutic agents.

775304-80-8

Post Buying Request

775304-80-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

775304-80-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 775304-80-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,5,3,0 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 775304-80:
(8*7)+(7*7)+(6*5)+(5*3)+(4*0)+(3*4)+(2*8)+(1*0)=178
178 % 10 = 8
So 775304-80-8 is a valid CAS Registry Number.

775304-80-8Relevant academic research and scientific papers

METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCIATED THEREWITH

-

Page/Page column 260, (2008/06/13)

The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.

COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY

-

, (2008/06/13)

The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 775304-80-8